1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
Riken Vitamin Co., Ltd.

Riken Vitamin Co., Ltd.

4526.T
Riken Vitamin Co., Ltd.JP flagTokyo Stock Exchange
3,115.00
JPY
+20.00
- -
90.92BMarket Cap
Riken Vitamin Co., Ltd.
4526.T
(Tokyo Stock Exchange)

Recent

price

3,115.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1,719.12
1,663.68
1,718.54
1,931.51
1,935.67
1,998.82
2,718.46
2,740.31
2,715.64
2,530.7
2,370.08
2,415.58
2,705.23
2,805.02
3,157.02
3,260.32
1,544.17
Revenue per Share
24.78
31.22
53.31
81.18
85.81
93.71
135.02
172.66
94.11
-272.46
-49.34
657.99
195.51
268.44
310.08
238.18
167.62
Basic EPS, GAAP
88.48
-21.82
-55.21
30.12
7.33
53.95
163.33
83.08
82.82
14.15
117.56
104.88
172.77
227.63
98.72
26.81
- -
Free Cash Flow per Basic Share
18.71
18.01
18.06
18.99
28.72
31.75
39.82
32.63
38.16
41.97
43
42.23
48.22
67.27
91.69
109.76
- -
Dividend per Share
1,197.06
1,210.33
1,250.51
1,338.48
1,401.43
1,468.52
1,755.78
1,863.71
1,913.06
1,549.27
1,456.62
2,072.04
1,867.48
2,079.67
2,223.24
2,402.07
2,291.04
Book Value per Share
1,200.22
1,227.76
1,326.83
1,497.35
1,694.51
1,668.22
1,657.06
1,818.65
1,834.24
1,406.72
1,402.52
2,007.35
2,155.83
2,320.05
2,583.56
2,788.64
2,543.56
Tangible Book Value per Share
45
45
45
44
44
44
32
33
33
33
33
33
33
33
30
30
30
Basic Weighted Avg Shares
77,912
75,398
77,568
85,419
85,603
88,072
87,181
89,515
89,024
82,974
77,722
79,231
88,750
91,484
95,582
96,300
46,871
Sales/Revenue/Turnover
7.18
3.4
4.64
5.89
5.43
6.85
8.1
7
5.66
6.4
1.76
7.37
8.07
10.24
9.13
7.17
10.19
Operating Margin (%)
3,250
3,113
3,268
3,407
3,902
3,388
3,496
3,639
3,915
4,072
3,955
3,736
3,718
3,330
3,204
4,677
- -
Depreciation Expense
1,123
1,415
2,406
3,590
3,795
4,129
4,330
5,640
3,085
-8,933
-1,618
21,582
6,414
8,755
9,388
7,035
5,088
Net Income, GAAP
60.39
43.35
33.64
32.19
27.63
32.02
29.15
32.06
39.96
- -
- -
- -
18.33
26.44
26.08
31.28
24.35
Effective Tax Rate (%)
1.44
1.88
3.1
4.2
4.43
4.69
4.97
6.3
3.47
-10.77
-2.08
27.24
7.23
9.57
9.82
7.31
10.86
Profit Margin (%)
27,108
25,160
25,767
29,014
28,040
28,918
29,390
31,002
29,353
16,324
514
34,569
39,202
35,404
44,570
46,793
37,566
Working Capital
716
234
148
1,010
738
435
19,192
17,000
15,243
13,870
451
13,860
11,254
4,115
6,541
5,200
2,806
LT Debt
55,140
56,363
60,728
67,253
76,082
74,406
53,916
60,109
60,786
46,789
46,674
66,539
71,371
76,643
79,200
83,379
78,130
Total Equity
3.39
2.23
3.47
4.47
3.96
4.63
5.7
4.83
3.46
- -
- -
- -
6.82
7.61
6.98
5.18
3.9
Return on Invested Capital (%)
1.92
2.5
3.98
5.55
5.62
5.89
5.74
6.93
3.99
- -
- -
- -
8.08
11.06
11.76
9.15
6.37
Return on Capital (%)
2.08
2.59
4.32
6.21
6.26
6.52
7.16
9.63
4.99
-15.74
-3.28
37.3
9.93
13.56
13.89
10.18
7.63
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
11,938
- -
11,713
LT Borrowings
4,115
- -
2,806
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
- -
30
Market Capitalization
84,594
84,018
78,373

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
66,521
- -
65,143
Cash, Cash Equivalents & STI
23,384
- -
22,648
Accounts Receivable, Net
21,884
- -
20,533
Inventories
18,581
- -
19,369
Total Current Liabilities
31,117
- -
27,577
Payables & Accruals
- -
- -
- -
ST Debt
11,938
- -
11,713
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.76%
13.17%
5.28%
Free Cash Flow
67.19%
-9.65%
-73.5%
Net Income, GAAP
-196.71%
-297.1%
-25.06%
Sales/Revenue/Turnover
1.02%
4.45%
0.75%
Total Cash Common Dividend
9.9%
18.89%
16.79%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
22,189
22,424
24,445
22,426
91,484
2025
- -
- -
- -
- -
95,582
2026
- -
- -
- -
- -
96,300

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
63.02
- -
- -
- -
268.44
2025
- -
- -
- -
- -
310.08
2026
- -
- -
- -
- -
238.18

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
67.27
2025
- -
- -
- -
- -
91.69
2026
- -
- -
- -
- -
109.76
Similar Companies
The Bombay Burmah Trading Corporation, Limited (BBTC.NS)
Swiss Water Decaffeinated Coffee Inc. (SWP.TO)
PRG Corporation Public Company Limited (PRG.BK)
Pilgrim's Pride Corporation (PPC)
The Kraft Heinz Company (KHC)
PT Sekar Bumi Tbk (SKBM.JK)
Business
Riken Vitamin Co., Ltd. manufactures and sells food ingredients, food improving agents, health care products, consumer and commercial foods, chemical improving agents, and vitamins primarily in Japan with overseas operations. The company offers household food products including non-oil dressings such as Riken Non-Oil Aojiso and Indo Kareya-san no Nazo Dressing, seaweed products like Fueru Wakame-chan, Furikakeru Zakuzaku Wakame, and Wakame Soup, extracts and seasonings such as Sozairyoku Dashi, retort-packed foods, salad-related products, seafood and meat extracts, and cut wakame; commercial food products and processed food raw materials for school lunch programs, restaurants, convenience stores, and processed food manufacturers; food improving agents including emulsifiers for bread, cake, whipped topping, coffee cream, margarine, tofu, jam, ice cream, noodles, and mashed potatoes, processed oils, natural colorants, vitamin E, anti-staling agents, foaming agents, coagulation agents, anti-sticking agents, texture improvers, and antioxidants; health care products such as crocetin (Crovit), mekabu fucoidan, carotenoids, vitamins, pork extract, and microencapsulation services; and chemical improving agents for anti-fogging, plasticization, lubrication, anti-static, thickening, cleaning, mold release, dispersion, and antioxidants, plus glycerol, polyglycerol, sorbitan, propylene glycol, specialty esters, and animal feed additives. Riken Vitamin operates eight factories in Japan including Tokyo, Osaka, Soka, Chiba, Kyoto, and others, and three overseas production facilities, with sales subsidiaries and application centers in North America, Southeast Asia, South Asia, China, the Middle East, Oceania, Europe, Africa, Latin America, Taiwan, and South Korea; subsidiaries include Riken Food Co., Ltd., Riken Vitamin USA, Inc., Tianjin Rikevita Food Co., Ltd., Rikevita (Malaysia) Sdn. Bhd., Rikevita (Singapore) Pte Ltd., Rikevita Fine Chemical & Food Industry (Shanghai) Co., Ltd., Guymon Extracts Inc., Rikevita (India) Private Limited, and Rikevita Turkey Food Industry Limited Company. Founded in 1949 as Riken Vitamin Oil Co., Ltd. from the Vitamin A Department of Riken Eiyou Yakuhin Co., Ltd. and renamed Riken Vitamin Co., Ltd. in 1980, the company is headquartered in Shinjuku-ku, Tokyo, Japan, and listed on the Tokyo Stock Exchange First Section (4526). Recent developments include the opening of a food-improving agent Application Center at Riken Vitamin USA, Inc. in June 2024; investments to expand the improving-agent factory at Tianjin Rikevita Food (new factory start in April 2025) and production facilities at Guymon Extracts (start in summer 2026); dissolution of the capital and business alliance with Kikkoman Corporation in FY2023 with repurchase of shares; establishment of Rikevita (Thailand) Co., Ltd. and Rikevita Viet Nam Co., Ltd. in 2025; launch of hit products Furikakeru Zakuzaku Wakame (Nikkei Trendy 2023) and Indo Kareya-san no Nazo Dressing in 2023; construction of a vitamin-mix wing at Tokyo Factory (start 2025); reduction of cross-shareholdings targeting under 20% of net assets by March 2025; and initiatives for eco-packaging, food loss reduction, and seaweed aquaculture revitalization.